MetLife (MET) | Stock Overview & Key Data
MetLife Performance Comparison
Stock Range
Today's Range
Low: $78.21
High: $81.36
on September 22, 2025
52 Week Range
Low: $65.21
High: $89.05
on April 7, 2025
on November 27, 2024
All-Time High: $89.05 on November 25, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$52.4B
EPS
5.89
P/E Ratio (TTM)
13.37
Forward P/E
8.12
P/B Ratio
1.90
PEG Ratio
-0.71
Div. Yield
2.10%
ROE
15.51%
Beta
0.856
Debt to Equity
171.72
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
5.61%
Profit Margin
5.87%
Returns and Earnings
Return on Assets (TTM)
0.59%
Return on Equity (TTM)
15.51%
EBITDA
$7.2B
Net Income (TTM)
$4.1B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$105.93
Quarterly Revenue Growth (YoY)
-2.70%
Quarterly Earnings Growth (YoY)
-22.90%
Dividend Information
Last 12-Month Dividend
$1.65
Current Dividend Yield
2.10%
3-Year Average Dividend Yield
0.77%
3-Year Average Annual Dividend
$1.93
3-Year Total Dividends
$5.78
Ex-Dividend Date
February 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| MetLife MET | 52.36B Large-cap | 0.65% | -0.63% | 1.70% | -3.80% | -0.98% | -1.82% | 33.23% | 115.20% |
| Aflac AFL | 57.44B Large-cap | -0.93% | -0.98% | 2.44% | -2.05% | 4.92% | -2.88% | 91.10% | 191.21% |
| Manulife Financial MFC | 53.51B Large-cap | -1.89% | 3.22% | 1.34% | 1.18% | 3.96% | 7.45% | 102.49% | 123.61% |
| Prudential PRU | 38.89B Large-cap | -2.47% | -6.41% | -2.60% | -9.18% | -13.04% | -14.87% | 19.90% | 61.01% |
| Unum UNM | 12.64B Large-cap | 1.34% | 8.55% | -5.21% | -8.93% | 4.07% | 29.41% | 95.62% | 329.30% |
| Globe Life GL | 11.41B Large-cap | 1.98% | 2.84% | 18.95% | 11.91% | 29.41% | 39.13% | 45.69% | 79.79% |
Ownership & Short Interest
Insider Ownership
0.25%
Institutional Ownership
91.63%
Shares Short
9M
Short Ratio
2.60
Short % of Shares Outstanding
1.64%
Average 10-Day Volume
3M
Average 90-Day Volume
3M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MET's 52-week high and low?
- In the last 52 weeks, MetLife reached a high of $89.05 (on November 27, 2024) and a low of $65.21 (on April 7, 2025).
- What is the market cap and P/E ratio for MET?
- Curious about MetLife's size and valuation? Its market capitalization stands at 52.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.37, and the forward P/E (looking ahead) is 8.12.
- Does MET pay dividends? If so, what's the yield?
- Yes, MetLife is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.10%, and the company has paid an average of $1.93 per share annually over the past 3 years.
- Who are MetLife's main competitors or similar companies to consider before investing?
When looking at MetLife, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Aflac
AFL57.44B Financial Services Insurance - Life -2.88% 91.10% Manulife Financial
MFC53.51B Financial Services Insurance - Life 7.45% 102.49% Prudential
PRU38.89B Financial Services Insurance - Life -14.87% 19.90% Unum
UNM12.64B Financial Services Insurance - Life 29.41% 95.62% Globe Life
GL11.41B Financial Services Insurance - Life 39.13% 45.69% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for MetLife Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of MetLife's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.51%, the Debt to Equity ratio from the most recent quarter is 171.72, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MET?
- Looking at MetLife's growth, its revenue over the trailing twelve months (TTM) was $73B. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.70%, and quarterly earnings saw a YoY growth of -22.90%.
- How much of MET stock is held by insiders and institutions?
- Wondering who owns MetLife stock? Company insiders (like executives and directors) hold about 0.25% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 91.63%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.